Rep. Tom Price (R-Ga.) faced intense questioning from Sen. Patty Murray (D-Wash.) on Wednesday over his decision to purchase Innate Immunotherapeutics stock after a conversation with Rep. Chris Collins (R-N.Y.). "Rep. Price, recent press reports about your investments in the Australian biotech company, Innate Immunotherapeutics, raise some curious questions about your judgments, and I want to review the facts," Murray began.